Covariate Effects on NSCLC Survival with 359 Patient Records

359 non-small cell lung cancer patient records were analyzed to investigate the impact of monoclonal antibody addition to platinum-based therapy on overall survival. The dataset includes demographic, clinical, and therapeutic data, with median survival rates, hazard ratios, and survival rates for different treatment protocols calculated. It was authored by Tarza Jamal Siahmansur and last updated on April 9, 2026.

Use Cases

• Compare median survival outcomes based on different treatment protocols mentioned in the description
• Analyze hazard ratios for covariates like metastasis, disease stage, age, and surgery
• Model 1-, 3-, and 5-year survival rates across treatment groups
• Identify independent predictors of overall survival from documented clinical variables

Strengths

• Contains 359 patient records with demographic, clinical, and therapeutic data
• Provides specific median survival months and hazard ratios for multiple treatment combinations
• Includes 1-, 3-, and 5-year survival rates with confidence intervals

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data may reflect temporal or source bias inherent to figshare

Provenance

Source

figshare

Freshness

Last updated 2026-04-09 17:41:04; freshness should be verified